Cargando…

Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy

The aim of this study was to characterize a 1:1 molar ratio of a pharmacologically relevant co-amorphous atorvastatin-irbesartan (ATR-IRB) system obtained by quench cooling of the crystalline ATR/IRB physical mixture for potential use in the fixed-dose combination therapy. The system was characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skotnicki, Marcin, Jadach, Barbara, Skotnicka, Agnieszka, Milanowski, Bartłomiej, Tajber, Lidia, Pyda, Marek, Kujawski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831949/ https://www.ncbi.nlm.nih.gov/pubmed/33477672 http://dx.doi.org/10.3390/pharmaceutics13010118

Ejemplares similares

Physical Ageing of Amorphous Indapamide Characterised by Differential Scanning Calorimetry
por: Drogoń, Agata, et al.
Publicado: (2020)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia
por: Ihm, Sang-Hyun, et al.
Publicado: (2019)

Physical Ageing of Amorphous Poly(lactic acid)-Indapamide System Studied by Differential Scanning Calorimetry
por: Skotnicki, Marcin, et al.
Publicado: (2023)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Anticrystal Engineering of Ketoprofen and Ester Local Anesthetics: Ionic Liquids or Deep Eutectic Mixtures?
por: Umerska, Anita, et al.
Publicado: (2020)

Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses
por: Mesallati, Hanah, et al.
Publicado: (2019)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Submerged Eutectic-Assisted, Solvent-Free Mechanochemical Formation of a Propranolol Salt and Its Other Multicomponent Solids
por: Bialek, Klaudia, et al.
Publicado: (2021)

Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry
por: Skotnicki, Marcin, et al.
Publicado: (2014)

Controlling the Polymorphism of Indomethacin with Poloxamer 407 in a Gas Antisolvent Crystallization Process
por: Cañellas, Fidel Méndez, et al.
Publicado: (2022)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019)

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2013)

A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
por: Alhazmi, Hassan A., et al.
Publicado: (2017)

Enhancement of the Physical Stability of Amorphous Sildenafil in a Binary Mixture, with either a Plasticizing or Antiplasticizing Compound
por: Knapik-Kowalczuk, Justyna, et al.
Publicado: (2020)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014)

Hot Melt Extrusion for Improving the Physicochemical Properties of Polydatin Derived from Polygoni cuspidati Extract; A Solution Recommended for Buccal Applications
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2023)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability
por: Kwon, Jaewook, et al.
Publicado: (2019)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Irbesartan improves arterial compliance more than lisinopril
por: Ali, Khalid, et al.
Publicado: (2009)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Late-Onset Rash from Irbesartan: An Immunological Reaction
por: Cardoso, Bárbara Kong, et al.
Publicado: (2019)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

Poly(vinyl methyl ether) hydrogels at temperatures below the freezing point of water—molecular interactions and states of water
por: Pastorczak, Marcin, et al.
Publicado: (2014)

Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!
por: Tchernev, Georgi, et al.
Publicado: (2019)

Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)

The effect of solution environment and the electrostatic factor on the crystallisation of desmotropes of irbesartan
por: Araya-Sibaja, Andrea M., et al.
Publicado: (2019)

A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
por: Dey, Sanjay, et al.
Publicado: (2014)

Pharmacokinetic and Safety Profiles of a Fixed‐Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3‐Period Replicate Crossover Study
por: Kim, Seokuee, et al.
Publicado: (2019)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
por: Mostafa, Eman A., et al.
Publicado: (2023)

Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan
por: Patel, Jaydeep, et al.
Publicado: (2011)

Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_68jgd9ukhis92csdudpk9dv98a